AliveCor's Kardia Mobile doesn't require wires, patches or gels. (AliveCor)


When was the company founded? 2011

How many full-time employees? 50

How much funding has it raised? AliveCor doesn’t disclose funding, but Crunchbase reports it has raised $43.5 million including a $30 million series D round that closed earlier this year.

What is the business and business model? AliveCor’s Kardia Mobile is positioned as a “personal EKG” that enables users to take a medical-grade EKG in just 30 seconds, with results sent to the user’s smartphone. Kardia Mobile was approved by the FDA in 2012 and provides instant analysis for detecting atrial fibrillation and normal sinus rhythm in an ECG. AliveCor sells the offering directly to consumers for a one-time charge of $99 for basic service; a premium service is available for $10 a month or $100 a year that includes features such as blood pressure tracking, weight and medication tracking, unlimited storage and history of heart health data and the ability for customers to email EKGs to themselves and their doctors.

What is the company's differentiator? AliveCor said its main competitors are traditional EKG recording devices, but it added that for consumers it competes against the perception that Kardia Mobile is a fitness device. Unlike traditional heart monitoring solutions, Kardia Mobile doesn’t require wires, patches or gels; users must only place their fingers on the electrodes. AliveCor also touts its affordability and immediacy, as well as its accuracy and FDA stamp of approval.

What’s next? The company recently released Kardia Pro, an AI-enabled platform allowing doctors to monitor Kardia Mobile patients for the early detection of atrial fibrillation, which is a leading cause of stroke. The new offering is designed to help patients to be “more proactive in their own healthcare,” and to help healthcare providers track readings and monitor cardiac risk factors between visits. Last September, the company began integrating data from Omron Healthcare’s home blood pressure devices to provide patients with a more complete of their heart health.

To return to the Fierce 15 homepage, click here.